Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label LHRH-receptor expressing tumors. Show all posts
Showing posts with label LHRH-receptor expressing tumors. Show all posts
Saturday, January 5, 2013

Aeterna Zentaris reaches SPA agreement with FDA for AEZS-108 Phase 3 trial in endometrial cancer

›
Aeterna Zentaris Inc. announced that it has reached an agreement with FDA  on a Special Protocol Assessment ("SPA") for an upco...
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.